View in EDS

Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging–targeted prostate biopsy grade groups are discordant.

Saved in:
Bibliographic Details
Title: Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging–targeted prostate biopsy grade groups are discordant.
Authors: Scuderi, Simone1 (AUTHOR), Group, Targeted Biopsies Prostate Cancer Collaborative (AUTHOR), Tin, Amy L2 (AUTHOR), Marra, Giancarlo3 (AUTHOR), Bianchi, Lorenzo4 (AUTHOR), Kesch, Claudia5 (AUTHOR), Soeterik, Timo F W6 (AUTHOR), Ploussard, Guillaume7 (AUTHOR), Zattoni, Fabio8 (AUTHOR), Ettala, Otto9 (AUTHOR)
Source: JNCI: Journal of the National Cancer Institute. Jan2026, Vol. 118 Issue 1, p76-84. 9p.
Database: Academic Search Ultimate
Description
ISSN:00278874
DOI:10.1093/jnci/djaf275